{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:35:05Z","timestamp":1789932905437,"version":"4.0.1"},"reference-count":58,"publisher":"Massachusetts Medical Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2009,7,16]]},"DOI":"10.1056\/nejmct0806938","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T21:41:37Z","timestamp":1247694097000},"page":"271-278","source":"Crossref","is-referenced-by-count":89,"title":["HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia"],"prefix":"10.1056","volume":"361","author":[{"given":"Jessica A.","family":"Kahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"r001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.8.813"},{"key":"r002","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00177-0"},{"key":"r003","doi-asserted-by":"publisher","DOI":"10.1086\/524875"},{"key":"r004","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.07.039"},{"key":"r006","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200523110-00004"},{"key":"r007","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2006.06.005"},{"key":"r008","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.10.042"},{"key":"r009","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.02.003"},{"key":"r010","doi-asserted-by":"publisher","DOI":"10.1038\/nrc798"},{"key":"r011","doi-asserted-by":"publisher","DOI":"10.1007\/s004050050236"},{"key":"r012","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.4.244"},{"key":"r013","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.111"},{"key":"r014","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-2922"},{"key":"r015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"r016","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600688"},{"key":"r017","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22527"},{"key":"r018","doi-asserted-by":"publisher","DOI":"10.1038\/nri1260"},{"key":"r019","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.07.004"},{"key":"r020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2008.09.006"},{"key":"r021","doi-asserted-by":"publisher","DOI":"10.1097\/00130404-200309000-00005"},{"key":"r022","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0461"},{"key":"r023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"r024","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60946-5"},{"key":"r025","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000253970.29190.5a"},{"key":"r026","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.03.049"},{"key":"r027","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68439-0"},{"key":"r028","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.109"},{"key":"r029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"r030","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60777-6"},{"key":"r031","unstructured":"Harper D, Gall S, Naud P, et al. Sustained immunogenicity and high efficacy against HPV-16\/18 related cervical neoplasia: long-term follow up through 6.4 years in women vaccinated with Cervarix. Presented at the 39th annual meeting of the Society of Gynecologic Oncologists, Tampa, FL, March 9\u201312, 2008."},{"key":"r032","doi-asserted-by":"publisher","DOI":"10.1086\/597307"},{"key":"r034","first-page":"1","volume":"55","author":"Eaton DK","year":"2006","journal-title":"MMWR Surveill Summ"},{"key":"r035","first-page":"1","volume":"56","author":"Markowitz LE","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"r036","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.02.002"},{"key":"r037","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053284"},{"key":"r038","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.6.342"},{"key":"r039","unstructured":"2009 Child and adolescent immunization schedules. Atlanta: Centers for Disease Control and Prevention. (Accessed June 22, 2009, athttp:\/\/www.cdc.gov\/vaccines\/recs\/schedules\/child-schedule.htm.)"},{"key":"r040","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.11.043"},{"key":"r041","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1735"},{"key":"r042","unstructured":"Summary tables of cervical cancer screening guidelines and recommendations for new technologies. Atlanta: Centers for Disease Control and Prevention. (Accessed June 22, 2009, athttp:\/\/www.cdc.gov\/std\/hpv\/ScreeningTables.pdf.)"},{"key":"r043","unstructured":"HPV vaccine information for young women. Atlanta: Centers for Disease Control and Prevention. (Accessed June 22, 2009, athttp:\/\/www.cdc.gov\/std\/hpv\/STDFact-HPV-vaccine-young-women.htm.)"},{"key":"r045","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70101-7"},{"key":"r046","unstructured":"Reports of health concerns following HPV vaccination. Atlanta: Centers for Disease Control and Prevention. (Accessed June 22, 2009, athttp:\/\/www.cdc.gov\/vaccinesafety\/vaers\/gardasil.htm.)"},{"key":"r047","unstructured":"Giuliano AR, Palefsky JM. The efficacy of quadrivalent HPV (types 6\/11\/16\/18) vaccine in reducing the incidence of HPV infection and HPV-related genital disease in young men. Presented at the EUROGIN [European Research Organization on Genital Infection] International Multidisciplinary Conference, Nice, France, November 12\u201315, 2008."},{"key":"r048","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604023"},{"key":"r049","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030138"},{"key":"r050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.2005.01.7103","volume":"24","author":"Schwarz TF","year":"2006","journal-title":"Proc Am Soc Clin Oncol"},{"key":"r051","unstructured":"Luna J, Saah AJ, Hood S, Bautista OM, Barr E. Safety, efficacy, and immunogenicity of quadrivalent HPV vaccine (Gardasil) in women aged 24-45. Presented at the 24th International Papillomavirus Conference, Beijing, November 3\u20139 2007."},{"key":"r052","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.120"},{"key":"r053","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.02.001"},{"key":"r054","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn038"},{"key":"r055","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.01779.x"},{"key":"r056","doi-asserted-by":"publisher","DOI":"10.1007\/BF02879925"},{"key":"r057","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2006.07.013"},{"key":"r058","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.1.7"},{"key":"r059","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.08.067"},{"key":"r060","first-page":"118","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"r061","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0b013e32830d0cf6"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMct0806938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,18]],"date-time":"2017-06-18T21:59:11Z","timestamp":1497823151000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMct0806938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,16]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7,16]]}},"alternative-id":["10.1056\/NEJMct0806938"],"URL":"https:\/\/doi.org\/10.1056\/nejmct0806938","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,16]]}}}